TIRZEPATIDE (20mg)
$149.00
Tirzepatide 10mg is a synthetic dual GIP and GLP‑1 receptor agonist supplied as a white lyophilized research peptide. Verified at 99% purity through HPLC and mass spectrometry. Intended strictly for laboratory research use only.
Product Overview
Tirzepatide is a synthetic 39-amino-acid peptide engineered for laboratory research applications. It contains a C20 fatty diacid moiety that enhances stability and albumin binding characteristics in controlled experimental models. This 10mg vial is supplied as a sterile white lyophilized powder with verified 99% purity.
Structural Composition
Tirzepatide consists of 39 amino acids and includes a C20 fatty diacid modification attached to a lysine residue. This structural feature is studied for its role in peptide stability and receptor interaction kinetics in laboratory settings.
Mechanism of Action (Research Context)
In controlled research environments, Tirzepatide is studied for its interaction with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
- Dual Receptor Binding: Investigated for activity at GIP and GLP-1 receptor sites in cell-based models.
- Signal Transduction Studies: Used in experiments examining receptor-mediated intracellular signaling cascades.
- Comparative Peptide Research: Applied in studies evaluating dual-agonist mechanisms versus single-receptor agonists.
Technical Specifications
| Purity | 99% (Validated by HPLC) |
| Quantity | 10mg per vial |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | ~4813.45 g/mol |
| Amino Acid Length | 39 Amino Acids |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20-fatty-acid)-Ala-Phe-Val-Gln-Trp-Leu-Met-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ |
| Physical Form | White Lyophilized Powder |
Key Product Features
- Dual GIP & GLP‑1 receptor research peptide
- 39-amino-acid synthetic sequence
- C20 fatty diacid modification for stability studies
- 99% purity verified via HPLC and Mass Spectrometry
- Vacuum-sealed vial for integrity preservation
- Manufactured under controlled laboratory standards
Quality Control & Analytical Verification
Each production batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis to confirm identity and purity. Certificate of Analysis (COA) documentation is available upon request.
Research FAQ
How should Tirzepatide be stored?
Store lyophilized material at 2–8°C for short-term storage. For extended preservation, maintain at -20°C under dry, light-protected conditions.
How does Tirzepatide differ from Semaglutide in laboratory research?
Tirzepatide is studied as a dual receptor agonist (GIP and GLP‑1), while Semaglutide primarily targets the GLP‑1 receptor. This distinction provides different experimental profiles in receptor signaling studies.
Is this product intended for clinical or personal use?
No. This product is strictly intended for laboratory research use only.
Compliance Notice
For research use only. Not for human consumption.
This product is intended strictly for laboratory research purposes.
Not for human or animal consumption, injection, or ingestion.
